文献速递衰弱、肌少症与跌倒老年慢病共病管理

衰弱对威尔士良性胸膜疾病患者死亡与住院的影响:队列研究

The effect of frailty on mortality and hospital admission in patients with benign pleural disease in Wales: a cohort study.
PubMed 文献 · Lancet Healthy Longev · 2024-07-31

作者认为诊断时评估衰弱有预后价值,中重度衰弱者健康快速下降。

要点

  • 良性胸膜疾病诊断时衰弱与全因死亡独立相关,且随衰弱程度加重而升高。
  • 中重度衰弱患者健康快速下降,可考虑优化照护与预先照护规划。
  • 研究校正年龄、性别、剥夺指数、吸烟、共病和胸膜疾病亚型。

核心结论

  • 在校正年龄与共病后,胸膜疾病诊断时的衰弱状态可作为预后指标。
  • 中度或重度衰弱患者健康快速下降,未来患者诊断时或应评估衰弱并可能受益于优化照护和预先照护规划。

研究设计与样本

  • 在威尔士开展队列研究,使用全国Secure Anonymised Information Linkage数据库识别2005年1月1日至2023年3月1日诊断的非恶性胸膜疾病且未已知离开威尔士的个体。
  • 主要结局为从诊断到全因死亡的时间,采用多水平混合效应Cox比例风险回归校正预设协变量:年龄、性别、威尔士多重剥夺指数五分位、吸烟状态、共病和胸膜疾病亚型。

临床怎么用

  • 对良性胸膜疾病患者,可在诊断时评估衰弱以辅助预后判断。
  • 对中度或重度衰弱患者,可考虑优化照护并开展预先照护规划。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Pleural disease is common, representing 5% of the acute medical workload, and its incidence is rising, partly due to the ageing population. Frailty is an important feature and little is known about disease progression in patients with frailty and pleural disease. We aimed to examine the effect of frailty on mortality and other relevant outcomes in patients diagnosed with pleural disease. METHODS: In this cohort study in Wales, the national Secure Anonymised Information Linkage databank was used to identify a cohort of individuals diagnosed with non-malignant pleural disease between Jan 1, 2005, and March 1, 2023, who were not known to have left Wales. Frailty was assessed at diagnosis of pleural disease using an electronic Frailty Index. The primary outcome was time from diagnosis to all-cause mortality for all patients. Data were analysed using multilevel mixed-effects Cox proportional hazards regression adjusting for the prespecified covariates of age, sex, Welsh Index of Multiple Deprivation quintile, smoking status, comorbidity, and subtype of pleural disease. FINDINGS: 54 566 individuals were included in the final sample (median age 66 years [IQR 47-77]; 26 477 [48·5%] were female and 28 089 [51·5%] were male). By the end of the study period, 25 698 (47·1%) participants had died, with a median follow-up of 1·0 years (IQR 0·2-3·6). There was an association between frailty and all-cause mortality, which increased as frailty worsened. Compared with fit individuals, there was increasing mortality for those with mild frailty (adjusted hazard ratio 1·11 [95% CI 1·08-1·15]; p<0·0001), moderate frailty (1·25 [1·20-1·31]; p<0·0001), and severe frailty (1·36 [1·28-1·44]; p<0·0001). INTERPRETATION: Independent of age and comorbidities, frailty status at diagnosis of pleural disease appeared to be useful as a prognostic indicator. Patients with moderate or severe frailty had a rapid decline in health. Future patients should be assessed for frailty at the time of diagnosis of pleural disease and might benefit from optimised care and advance care planning. FUNDING: Cardiff University's Wellcome Trust iTPA funding award.

来源:Lancet Healthy Longev,查看原文。版权归原作者所有。

引用

  1. Short R, Carter B, Verduri A, et al. The effect of frailty on mortality and hospital admission in patients with benign pleural disease in Wales: a cohort study. Lancet Healthy Longev. 2024. PMID: 39096917. doi:10.1016/S2666-7568(24)00114-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。